• Statistics

    • Heartburn, acid regurgitation, excess of burping/belching, increased abdominal bloating, nausea, a feeling of abnormal or slow digestion, or early satiety are all symptoms that are described by the term "dyspepsia". The most common cause of dyspepsia is gastroesophageal reflux disease (GERD).
    • Worldwide sales for indigestion and heartburn remedies totaled $CDN 9.1 billion in 2008.
    • Canada is ranked as the 12th largest consumer of indigestion and heartburn remedies in the world. In 2008, Canadian sales were $164 million. This is a substantial increase from 2003 in where sales totaled just $108 million.
    • Patients concerns about indigestion costs the Canadian health care system $460 million each year.
    • In the 1980s, the average length of hospital stay for dyspeptic patients was 7 days. Since 2002, this has decreased to 5 days reducing the economic burden of this disease by $16.3 million per year).
    • The risk for developing Barrett's esophagus in dyspeptic patients is higher than for non-dyspeptic patients. The disease is considered a premalignant condition that may lead to progressive dysplasia and adenocarcinoma.
    • In Canada, the majority of dyspepsia sufferers have erosive esophagitis which responds well to acid suppressive prescription drugs.

Enhancing lifelong health

The Canadian Digestive Health Foundation believes our ability to help establish, enrich and protect a healthy gut microbiota is the key to lifelong health